These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7252979)

  • 21. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
    Federico P; Veale WL; Pittman QJ
    Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids.
    Manning M; Przybylski J; Grzonka Z; Nawrocka E; Lammek B; Misicka A; Cheng LL; Chan WY; Wo NC; Sawyer WH
    J Med Chem; 1992 Oct; 35(21):3895-904. PubMed ID: 1433200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged inhibition of pressor response to vasopressin by a potent specific antagonist, [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid) 2-(O-methyl)tyrosine]arginine-vasopressin.
    Pang CC; Leighton KM
    Can J Physiol Pharmacol; 1981 Sep; 59(9):1008-12. PubMed ID: 6895346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of 8-D-arginine vasopressin analogues, modified in position 1 as antagonists of the vasopressor response to the parent hormone.
    Lammek B; Derdowska I; Melin P
    Pol J Pharmacol Pharm; 1988; 40(4):423-8. PubMed ID: 3222181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors.
    Ala Y; Morin D; Mahé E; Cotte N; Mouillac B; Jard S; Barberis C; Tribollet E; Dreifuss JJ; Sawyer WH; Wo NC; Chan WY; Kolodziejczyk AS; Cheng LL; Manning M
    Eur J Pharmacol; 1997 Jul; 331(2-3):285-93. PubMed ID: 9274991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of vasopressin antagonist on vasopressin binding, adenylate cyclase activation, and water flux.
    Kim JK; Dillingham MA; Summer SN; Ishikawa S; Anderson RJ; Schrier RW
    J Clin Invest; 1985 Oct; 76(4):1530-5. PubMed ID: 2997281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frog glomerular vasotocin receptors resemble mammalian V1b receptors.
    Ammar A; Rajerison RM; Roseau S; Bloch-Faure M; Butlen D
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1198-208. PubMed ID: 7977846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological activities of some new arginine vasopressin analogues containing unusual amino acids.
    Varga C; Somlai C; Baláspiri L; László FA
    Acta Physiol Hung; 1993; 81(2):183-92. PubMed ID: 8197874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, antidiuretic and pressor activities of [arginine4]arginine-vasopressin and two related analogues.
    Rekowski P; Lammek B; Melin P; Ragnarsson U; Kupryszewski G
    Acta Chem Scand B; 1985; 39(6):453-7. PubMed ID: 4060959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and some pharmacologic properties of five novel V1 or V1/V2 antagonists of AVP.
    Lammek B; Wang YX; Derdowska I; Franco R; Gavras H
    Peptides; 1989; 10(5):1109-12. PubMed ID: 2608555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.
    Stoev S; Cheng LL; Olma A; Klis WA; Manning M; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1999 Mar; 5(3):141-53. PubMed ID: 10323558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [1-deaminopenicillamine,4-valine]-8-D-arginine-vasopressin, a highly potent inhibitor of the vasopressor response to arginine-vasopressin.
    Manning M; Lowbridge J; Stier CT; Haldar J; Sawyer WH
    J Med Chem; 1977 Sep; 20(9):1228-30. PubMed ID: 926126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Acetyl-[2-(O-methyl)tyrosine]arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin.
    Jones DA; Sawyer WH
    J Med Chem; 1980 Jun; 23(6):696-8. PubMed ID: 7392038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for independent actions of vasopressin on renal inner medullary cyclic AMP and prostaglandin E production: relationship of the prostaglandin E response to hormone pressor activity.
    Campbell HT; Craven PA; DeRubertis FR
    Metabolism; 1982 Oct; 31(10):1035-41. PubMed ID: 6290836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery.
    Clineschmidt BV; Lis EV
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):72-84. PubMed ID: 2950833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the pharmacologic properties of a vasopressin antagonist in Brattleboro rats.
    Mah SC; Hofbauer KG
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1028-32. PubMed ID: 2968448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate.
    László FA; Csáti S; Baláspiri L
    Acta Endocrinol (Copenh); 1984 May; 106(1):56-60. PubMed ID: 6730855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin.
    Manning M; Stoev S; Kolodziejczyk A; Klis WA; Kruszynski M; Misicka A; Olma A; Wo NC; Sawyer WH
    J Med Chem; 1990 Nov; 33(11):3079-86. PubMed ID: 2231609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.